2.1 Patients
Patients suspicious of AE were tested for autoimmune antibodies, and patients considered as CNS demyelinating disease were tested for demyelination antibodies. The flow diagram of inclusion criteria was shown in Figure 1A. Exclusion criteria included: (1) follow-up month was less than 3 months; (2) patient information was insufficient; (3) patient was diagnosed as other antibodies positive AE or AQP4-IgG seropositive NMOSD. After data collecting, ten patients fulfilled the criteria and diagnosed as MOGAD overlapping with NMDAR encephalitis between January 2018 and June 2023 at the Second Xiangya Hospital of Central South University.